Print


Banner MANCHESTER 

Aim of the Course

This course will address current treatments for specific tumour groups and future challenges for developping services in different health care settings.

It will focus on delivering evidence-based clinical practice and achieving quality assured outcomes for patients undergoing abdominal and pelvic cytoreductive surgery and intraperitoneal chemotherapy.
                                                      
Chair:
Sarah O'Dwyer, The Christie NHS Foundation Trust, Manchester, UK                                                

Co-Chair: 
Santiago González-Moreno, MD Anderson Cancer Center, Madrid, SP

Invited Faculty
Thomas Bachleitner-Hofmann, Medical University of Vienna, AT
Norman J. Carr, Basingstoke and North Hampshire Hospital, Basingstoke, UK
Tom Cecil, Basingstoke and North Hampshire Hospital, Basingstoke, UK
Marcello Deraco, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT
Charles Honoré, Institut de Cancérologie Gustave Roussy, Villejuif, FR
Brendan Moran,
Basingstoke and North Hampshire Hospital, Basingstoke, UK
Pompiliu Piso, St. John of God Hospital, Regensburg, DE
Beate Rau,
Charité Campus Mitte, Berlin, DE
Josefin Segelman,
Karolinska Institut, Solna, Stockholm, SE
Paul H Sugarbaker,
Washington Cancer Center, Washington, USA
Kurt Van der Speeten,
Ziekenhuis Oost-Limburg, Genk, BE
Vic Verwaal,
The Netherlands Cancer Institute, Amsterdam, NL
Willemien van Driel,
The Netherlands Cancer Institute, Amsterdam, NL


Local Faculty

Omer Aziz
Rahul Deshpande
Paul Fulford
Vidya Kasipandian
Rohit Kochlar
Andrew Renehan
Mark Saunders
Chelliah Selvasekar
Malcom Wilson

    

Ideal advanced Course Candidate

  • Consultant surgeons/gynaecologists/oncologists
  • Senior residents/fellows surgery/gyneacology/oncology
  • Senior nurse practitioners in PSM/oncology

Educational Methods

  • Live surgical sessions with interactive discussions
  • Video sessions/workshops on surgical technique and HIPEC
  • Plenary lectures
  • MDT case management
  • Interactive voting on key topics

Participation                                   

Participation fee is 650 EUR  for ESSO members and 800 EUR for non members. The fee includes registration to the course, coffee breaks, lunches and a social dinner.  

Registration Procedure

Application must include

Programme

Click here to download the programme     

 
Media partner

Logo Medtub 2

 

 

           

 

 

 

 

 

 

 

 

            

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
















 





ESSO Endorsed and Recommended events

ESSO ENDORSED 1 ESSO Endorsed and Recommended events
ESSO also supports or recommends scientific events organised by other medical societies, hospitals or institutions that are deemed relevant and of particular interest for the surgical oncology community. All events listed on the ESSO website have been reviewed and approved by the ESSO Website & Editorial Committee. Click here to access the list of endorsed and recommended events.